Phase 2, Single-Site, Open-Label, Randomized, 2-ArmParallel Study to Assess the Efficacy and Safety ofRyanodex® (EGL-4104) as Adjuvant Treatment inSubjects With Exertional Heat Stroke (EHS
عنوان الدراسة
Phase 2, Single-Site, Open-Label, Randomized, 2-ArmParallel Study to Assess the Efficacy and Safety ofRyanodex® (EGL-4104) as Adjuvant Treatment inSubjects With Exertional Heat Stroke (EHS
داعم الدراسة
Eagle Pharmaceuticals
دواء الدراسة
Dantrolene
رقم بروتوكول الدراسة
EGL-4104-C-1502
حالة الدراسة
Completed
موقع الدراسة
King Fahad Medical City (Riyadh)
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.